Dave Gonigam

Dave Gonigam

Dave Gonigam has been managing editor of The 5 Min. Forecast since September 2010. Before joining the research and writing team at Agora Financial in 2007, he worked for 20 years as an Emmy award-winning television news producer.

Dave Gonigam's Recent Articles

5 Min. ForecastBold Predictions from the Bubble Crowd

Dave Gonigam

Even if tech giants like Facebook and Apple have a down day now and then, that doesn't mean they aren't still sound companies with upside potential. Of course, some people aren't convinced... which is why the word "bubble" has now reentered the conversation. Dave Gonigam has the full story...


5 Min. ForecastHow to Profit On the Back of an “Activist Investor”

Dave Gonigam

Since the invention of the "shareholder rights plan" (i.e. the "poison pill"), most companies are relatively immune to hostile takeovers. But according to Dave Gonigam that could all change thanks to one activist investor. And if you're savvy enough, you may just be able to follow his lead for big gains. Read on...


5 Min. ForecastThe 2 Forces Driving the Current Stock Market Boom

Dave Gonigam

Stocks have started off this week pretty flat. But is more volatility to come as the week progresses? Today, Dave Gonigam takes a look at a few scenarios for the rest of this week, and for 2014 as a whole - specifically relaying what one analyst sees as the two main forces currently driving the market boom. Read on...


5 Min. ForecastBig Gains from an Earnings Season Surprise

Dave Gonigam

It's earnings season, and that means the "expectations game" is in full swing. Of course, with so much speculation involved, this often ends up being a "contradiction game" between various media outlets. Today, Dave Gonigam explains how to sift through the noise and play a few earnings surprises for big gains. Read on...


5 Min. ForecastProfit With the Sharks in the Biotech Market

Dave Gonigam

According to a Wall Street Journal headline, the recent rout in biotech stocks thoroughly "perplexed" the financial analysts. Today, Dave Gonigam relays why the very idea of that headline is so ludicrous, and why biotech investing is like swimming with some fiercest sharks in the investment world. Read on...


5 Min. ForecastTwo (Essential) “Heartbleed” Solutions

Dave Gonigam

If anyone browsing the web over the last few days has logged into any website there's a good chance they've come in contact with a computer bug called heartbleed. Internet users might just have to change their passwords across the sites they use. Dave Gonigam lays out the story... and proposes two potential solutions...


5 Min. ForecastWise Investments in the Next Global Arms Race

Dave Gonigam

Thanks to years of mismanagement and political corruption, Ukraine is more of a basket case, instead of the agricultural breadbasket it should be. And no amount of Western involvement is going to change that. Dave Gonigam explains how this situation is likely to play out, and offers a few tips on what to do in the short term...


5 Min. ForecastEnergy Stocks Reach Bargain Basement Prices

Dave Gonigam

With so much being made of the resurgence of the US energy industry, it's hard to believe that energy stocks are languishing near a 15-year bottom. But that's what's happening right now. Of course, when a market bottoms-out, that can also mean a tremendous buying opportunity. Is this one of those moments? Dave Gonigam investigates...


5 Min. ForecastHarvard Business School: Higher Learning for B.S. Artists

Dave Gonigam

The leaders of tomorrow are being schooled in highly regarded institutions like Princeton, Yale and, of course, Harvard. But when you look at the list of alumni from Harvard's Business School, it becomes clear that they've graduated with more than just a degree is business. Dave Gonigam explains...


5 Min. ForecastGene Editing: The Key to Curing HIV

Dave Gonigam

Medical research is moving at lightning speed. But perhaps the most exciting breakthroughs are coming in the field of gene editing. Today, Dave Gonigam sits down with biotech guru Ray Blanco for a frank discussion on genetic research, the next great breakthroughs and the prospect of curing HIV, for good. Read on...